TRCT
BLU

Tower Research Capital (TRC)’s BELLUS Health Inc. BLU Stock Holding History

Tower Research Capital (TRC)’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,223
Closed -$73K – 6519
2023
Q1 		$73K Sell
10,223
-490
-5% -$3.8K ﹤0.01% 2169
2022
Q4 		$88K Buy
10,713
+1,075
+11% +$10K ﹤0.01% 1941
2022
Q3 		$103K Buy
9,638
+7,688
+394% +$81.7K ﹤0.01% 2546
2022
Q2 		$18K Buy
1,950
+309
+19% +$2.53K ﹤0.01% 3930
2022
Q1 		$11K Buy
1,641
+299
+22% +$1.93K ﹤0.01% 4246
2021
Q4 		$11K Buy
+1,342
New +$8.91K ﹤0.01% 4497
2020
Q4 		– Sell
-9,183
Closed -$21K – 5495
2020
Q3 		$21K Buy
9,183
+8,669
+1,687% +$24.6K ﹤0.01% 3857
2020
Q2 		$5K Buy
+514
New +$5.21K ﹤0.01% 4311

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Tower Research Capital (TRC)'s BLU Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 10,223 shares — an estimated $73K sold.

Tower Research Capital (TRC) first reported a position in BLU in Q2 2020 and held it in 8 quarters. The position peaked at $103K in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Tower Research Capital (TRC) reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 10,223 BELLUS Health Inc. shares in Q2 2023, an estimated $73K.
  • Tower Research Capital (TRC) first reported a position in BELLUS Health Inc. in Q2 2020 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s BELLUS Health Inc. position peaked at $103K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.